Abstract
Tuberculosis is an infection caused by Mycobacterium tuberculosis or related organisms such as Mycobacterium bovis. M. tuberculosis, a slow-growing, acid-faststaining bacillus, is the most common cause of tuberculosis in man and will be the focus of this chapter. Tuberculosis is most commonly transmitted from person to person via the aerial route, and most individuals who are infected do not develop clinical disease. About 5% of those infected may develop clinical manifestations such as pulmonary or miliary disease, and disease may occur at the time of primary infection or may occur years later. Malnutrition and other immunosuppressive disorders such as human immunodeficiency virus (HIV) infection increase the risk of developing clinical disease (Fig. 1). In the absence of effective chemotherapy, tuberculosis is characterized by wasting and high mortality. The association of poor nutrition with tuberculosis is evident in older terms for tuberculosis such as the Greek term “phthisis” or “to waste away” and “consumption.”
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Raviglione MC, Snider DE, Kochi A. Global epidemiology of tuberculosis: morbidity and mortality of a worldwide epidemic. JAMA 1995; 273: 220–226.
De Cock KM, Soro B, Coulibaly IM, Lucas SB. Tuberculosis and HIV infection in sub-Saharan Africa. JAMA 1992; 268: 1581–1587.
Pablos-Mendez A, Raviglione M, Laszlo A, Binkin N, Rieder HL, Bustreo F, et al. Global surveillance for antituberculous-drug resistance, 1994–1997. N Engl J Med 1998; 338: 1641–1649.
Small PM, Hopewell PC, Singh SP, Paz A, Parsonnet J, Ruston DC, et al. The epidemiology of tuberculosis in San Francisco: a population-based study using conventional and molecular methods. N Engl J Med 1994; 330: 1703–1709.
Hermans PW, Messadi F, Guebrexabher H, van Soolingen D, de Haas PE, Heersma H, et al. Analysis of the population structure of Mycobacterium tuberculosis in Ethiopia, Tunisia, and The Netherlands: usefulness of DNA typing for global tuberculosis epidemiology. J Infect Dis 1995; 171: 1504–1513.
Smith GE, Ruffer MA. Pott’che Krankheit an einer ägyptischen Mumie. University of Giessen, Germany: A. Töpelmann, 1910.
Buikstra JE, Baker BJ, Cook DC. What diseases plagued the ancient Egyptians? A century of controversy considered. In: Biological Anthropology and the Study of Ancient Egypt. Davies WV, Walker R, eds. London: British Museum Press, 1993.
Allison MJ, Mendoza D, Pezzia A. Documentation of a case of tuberculosis in pre-Columbian America. Am Rev Resp Dis 1973; 107: 985–891.
Chadwick J, Mann WN. The Medical Works of Hippocrates. Oxford: Blackwell Scientific Publications, 1950.
Aretaeus the Cappadocian. The Extant Works of Aretaeus, the Cappadocian. Edited and translated by Francis Adams. London: Sydenham Society, 1856.
Galen. Librorum pars prima [-quintal (5 vols). Venetiis, in aedibus Aldi, et Andreae Asulani soceri, 1525.
Crawfurd R. The King’s Evil. Oxford: Clarendon Press, 1911.
Bloch M. The Royal Touch: Sacred Monarchy and Scrofula in England and France. Montreal: McGill, Queen’s University Press, 1973.
Morton R. Phthisiologia: or A Treatise of Consumptions, 2nd ed. London: W. and J. Innys, 1720.
Cullen W. First Lines of the Practice of Physic. 4 vols. Edinburgh: C. Elliot, and London: T. Cadell, 1786.
King LS. Medical Thinking: A Historical Preface. Princeton: Princeton University Press, 1982.
Ackerknecht EH. Medicine at the Paris Hospital, 1794–1848. Baltimore: Johns Hopkins Press, 1967.
Foucault M. The Birth of the Clinic: An Archaeology of Medical Perception. New York, NY: Pantheon Books, 1973.
Bayle GL. Recherches sur la phthisie pulmonaire. Paris: Gabon, 1810.
Laennec RTH. De l’auscultation médiate, ou traité de diagnostic des maladies des poumons et du coeur. Paris: J. A. Brosson and J. S. Claudé, 1819.
Schwann T. Microscopical Researches into the Accordance in the Structure and Growth of Animals and Plants. London: Sydenham Society, 1847.
Villemin JA. Etudes sur la tuberculose: preuves rationelles et expérimentales de sa spécifité et de son inoculabilité. Paris: J.B. Baillière, 1868.
Koch R. Die Aetiologie der Tuberkulose. Berlin klin Wschr 1882; 19: 221–230.
Koch R. Weitere Mittheilungen über ein Heilmittel gegen Tuberkulose. Dtsch med Wschr 1890; 16: 1029–1032, 1891; 17: 101–102, 1189–1192.
Bodington G. Essay on the Treatment of and Cure of Pulmonary Consumption. London, Longmans and Company, 1840.
Rothman SM. Living in the Shadow of Death: Tuberculosis and the Social Experience of Illness in American History. Baltimore and London: Johns Hopkins University Press, 1994.
Bryder L. Below the Magic Mountain: A Social History of Tuberculosis in Twentieth-Century Britain. Oxford: Claredon Press, 1988.
Rollier A. Die Heliotherapie der Tuberkulose. Berlin: J. Springer, 1913.
Forlanini C. A contribuzione della terapia chirurgica della tisi; ablazione de polmone? pneumotorace artificiale? Gazz Osp Clin 1882; 3: 537–705.
Bates JH, Stead WW. The history of tuberculosis as a global epidemic. Med Clin North Am 1993; 77: 1205–1217.
Williams CJB, Williams CT. On the nature and treatment of pulmonary consumption. Lancet 1868; i:369–780; ii:3–214.
Bennett JH. Treatise on the Oleum Jecoris Aselli, or Cod Liver Oil, as a Therapeutic Agent in Certain Forms of Gout, Rheumatism, and Scrofula, with Cases. London: S. Highley, 1841.
Schütte D. Beobachtungen über den Nutzen des Berger Leberthrans (Oleum jecoris aselli, von Gadus Asellus L.). Archiv f. med. Erfahrung 1824; 79–92.
Taufflieb E. De l’huile de foie de morue et de son usage en médecine. Bull Tray Soc Med Prat Paris 1852; 45–135.
Williams CJB, Williams CT. Pulmonary Consumption, Its Etiology, Pathology, and Treatment. 2nd ed. London: Longmans, Green, and Co., 1889.
Bibliographical Record. The first annual report of the Hospital for Consumption and Diseases of the Chest, London, 1849. London J Med 1850; 2: 37–46.
Greenhow EH. On the employment of cod-liver oil in phthisis. With cases. Lancet 1854; ii: 502–545.
McConkey M. The treatment of intestinal tuberculosis with codliver oil and tomato juice. Am Rev Tuberc 1930; 21: 627–635.
Tui C, Kuo NH, Schmidt L. The protein status in pulmonary tuberculosis. Am J Clin Nutr 1954; 2: 252–264.
Pottenger FM Jr, Pottenger FM. Adequate diet in tuberculosis. Am Rev Tuberc 1946; 54: 219.
Calmette LCA, Guérin C, Négre L, Boquet A. Sur la vaccination préventive des enfants nouveau-nés contre la tuberculose par le B. C. G. Ann Inst Pasteur 1927; 41: 201–232.
World Health Organization Expert Committee on Tuberculosis. Ninth Report. Technical Report Series No. 552. Geneva: WHO, 1974.
Colditz GA, Brewer TF, Berkey CS, Wilson ME, et al. Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature. JAMA 1994; 271: 698–702.
Comstock GW. Field trials of tuberculosis vaccines: How could we have done them better? Controlled Clin Trials 1994; 15: 247–276.
Hinshaw HC, Feldman WH. Streptomycin in the treatment of clinical tuberculosis: a preliminary report. Proc Mayo Clin 1945; 20: 313–318.
Medical Research Council. Streptomycin treatment of pulmonary tuberculosis. BMJ 1948; 2: 769–782.
Marks HM. The Progress of Experiment: Science and Therapeutic Reform in the United States, 1900–1990. Cambridge, UK: Cambridge University Press, 1997.
Robitzek EH, Selikoff IJ, Orstein GG. Chemotherapy of human tuberculosis with hydrazine derivatives of isonicotinic acid. (Preliminary report of representative cases.) Q Bull Sea View Hosp 1952; 13: 27–51.
McKeown T. The Modern Rise of Population. New York, NY: Academic, 1976.
McKeown T. The Role of Medicine: Dream, Mirage, or Nemesis? Princeton: Princeton University Press, 1979.
Barnes DS. The Making of a Social Disease: Tuberculosis in Nineteenth Century France. Berkeley and Los Angeles: University of California Press, 1995.
Flick LF. The Development of our Knowledge of Tuberculosis. Philadelphia: privately printed, 1925.
Brown L. The Story of Clinical Pulmonary Tuberculosis. Baltimore: Willliams and Wilkins, 1941.
Waksman S. The Conquest of Tuberculosis. Berkeley: University of California Press, 1964.
Coury C. La tuberculose au cours des ages. Grandeur et d \142 clin d’un maladie. Suresne: Lepetit S.A., 1972.
Dubos R, Dubos J. The White Plague: Tuberculosis, Man, and Society. Boston: Little, Brown and Co., 1952.
Daniel TM. Captain of Death: The Story of Tuberculosis. Rochester: University of Rochester Press, 1997.
Bates B, Rothman S, Ellison D. Bargaining for Life: A Social History of Tuberculosis, 1876–1938. Philadelphia: University of Pennsylvania Press, 1992.
Ott K. Fevered Lives: Tuberculosis in America Culture since 1870. Cambridge and London: Harvard University Press, 1996.
Johnston W. The Modern Epidemic: A History of Tuberculosis in Japan. Cambridge: Council on East Asian Studies, 1995.
Sudre P, ten Dam G. Tuberculosis: a global overview of the situation today. Bull WHO 1992; 70: 149–159.
Styblo K. Overview and epidemiologic assessment of the current global tuberculosis situation with emphasis on control in developing countries. Rev Infect Dis 1989; 11: 5339–5345.
Loudon RG, Spohn SK. Cough frequency and infectivity in patients with pulmonary tuberculosis. Am Rev Resp Dis 1969; 99: 109–111.
Stead WW. Undetected tuberculosis in prison. JAMA 1978; 240: 2544–2547.
Nolan CM, Elarth AM, Barr H, Saeed AM, Risser DR. An outbreak of tuberculosis in a shelter for homeless men: a description of its evolution and control. Am Rev Resp Dis 1991; 143: 257–261.
Stead WW, Lofgren JP, Warren E, Thomas C. Tuberculosis as an endemic and nosocomial infection among the elderly in nursing homes. N Engl J Med 1985; 312: 1483–1487.
Comstock GW, Liveway VT, Woolpert SF. The prognosis of a positive tuberculin reaction in childhood and adolescence. Am J Epidemiol 1974; 99: 131–138.
Daley CL, Small PM, Schecter GF, Schoolnik GK, McAdam RA, Jacobs WR Jr, Hopewell PC. An outbreak of tuberculosis with accelerated progression among persons infected with the human immunodeficiency virus. N Engl J Med 1992; 326: 231–235.
Moreno S, Miralles P, Diaz MD, Baraia J, Padilla B, Berenguer J, Alberdi JC. Isoniazid preventive therapy in human immunodeficiency virus-infected persons. Long term effect on the development of tuberculosis and survival. Arch Intern Med 1997; 157: 1729–1734.
Whalen CC, Johnson JL, Okwera A, Hom DL, Huebner R, Mugyenyi P, et al. A trial of three regimens to prevent tuberculosis in Ugandan adults infected with the human immunodeficiency virus. N Engl J Med 1997; 337: 801–808.
Hawken MP, Meme HK, Elliott LC, Chakaya JM, Morris JS, Githui WA, et al. Isoniazid preventive therapy for tuberculosis in HIV-1-infected adults: results of a randomised trial. AIDS 1997; 11: 875–882.
Moreno S, Baraia-Etxaburu J, Douza E. Risk for developing tuberculosis among anergic patients infected with HIV. Ann Intern Med 1993; 119: 194–198.
Chintu C, Ganapati B, Luo C, Ravilgione M, Diwan V. Seroprevalence of human immunodeficiency virus type 1 infection in Zambian children with tuberculosis. Pediatr Infect Dis J 1993; 12: 499–504.
Sassan-Morokro M, De Cock KM, Ackah A, Vetter KM, Doorly R, Brattegaard K, et al. Tuberculosis and HIV infection in children in Abidjan, Cote d’Ivoire. Trans R Soc Trop Med Hyg 1994; 88: 178–181.
Kamat SR, Dawson JJY, Devadata S, Fox W, Janardhanam BJ, Radhakrishna S. A controlled trial of the influence of segregation of tuberculosis patients for one-year on the attack rate of tuberculosis in a 5-year period in close family contacts in South India. Bull WHO 1966; 34: 517–532.
Centers for Disease Control and Prevention (CDC). Prevention and control of tuberculosis in U.S. communities with at-risk minority populations. MMWR 1992; 41: 1–11.
McAdam JM, Brickner PW, Scharer LL, Crocco JA, Duff AE. The spectrum of tuberculosis in a New York City men’s shelter clinic (1982–1988). Chest 1990; 97: 798–805.
CDC. Prevention and control of tuberculosis in correctional facilities. MMWR 1996; 45: 1–23.
Cantwell MF, Snider DE Jr, Cauthen GM, Onorato IM. Epidemiology of tuberculosis in the United States, 1985 through 1992. JAMA 1994; 272: 535–539.
Zuber PL, McKenna MT, Binkin NJ, Onorato IM, Castro KG. Long-term risk of tuberculosis among foreign-born persons in the United States. JAMA 1994; 278: 304–307.
Cohn ML, Middlebrook G, Russel WE Combined drug treatment of tuberculosis. I. Prevention of emergence of mutant populations of tubercle bacilli resistant to both streptomycin and isoniazid in vitro. J Clin Invest 1959; 38: 1349–1355.
Mahmoudi A, Iseman MD. Pitfalls in the care of patients with tuberculosis: common errors and their association with the acquisition of drug resistance. JAMA 1993; 270: 65–68.
Bloch AB, Cauthen G, Onorato IM, Dansbury KG, Kelly GD, Driver CR, Snider DE Jr. Nationwide survey of drug-resistant tuberculosis in the United States. JAMA 1994; 271: 665–671.
Toossi Z. Cytokine circuits in tuberculosis. Infect Agents Dis 1996; 5: 98–107.
Takashima T, Ueta C, Tsuyuguchi I, Kishimoto S. Production of tumor necrosis factor by monocytes from patients with pulmonary tuberculosis. Infect Immun 1990; 58: 3286–3292.
Wallis RS, Vjecha M, Amir-Tahmasseb M, Okwera A, Byekwaso F, Nyole S, et al. Influence of tuberculosis on human immunodeficiency virus enhanced cytokine expression and elevated 32-microglobulin in HIV-1-associated tuberculosis. J Infect Dis 1993; 167: 43–48.
Ogawa T, Uchida H, Kusumoto Y, Mori Y, Yamamura Y, Hamada S. Increase in tumor necrosis factor alpha and interleukin-1 secreting cells in peripheral blood mononuclear cells from subject infected with Mycobacterium tuberculosis. Infect Immun 1991; 59: 3021–3025.
Hirsch CS, Hussain R, Toossi Z, Dawood G, Shahid F, Ellner JJ. Cross-modulation by transforming growth factor beta in human tuberculosis: suppression of antigen-driven blastogenesis and interferon gamma production. Proc Natl Acad Sci USA 1996; 93: 3193–3198.
Toossi Z, Gogate P, Shiratsuchi H, Young T, Ellner JJ. Enhanced production of transforming growth fatctor-ß (TGF-(3) by blood monocytes from patients with active tuberculosis and the presence of TGF-13 in tuberculous granulomatous lungs lesions. J Immunol 1995; 54: 465–473.
Kindler V, Sappino AP, Grau GE, Piguet PF, Vassalli P. The inducing role of tumor necrosis factor in the development of bactericidal granulomas during BCG infection. Cell 1989; 56: 731–740.
Valone SE, Rich EA, Wallis RS, Ellner J. Expression of tumor necrosis factor a in-vitro by human mononuclear phagocytes stimulated with whole Mycobacterium bovis BCG and mycobacterial antigens. Infect Immun 1988; 56: 3313–3315.
Nkhoma WA, Harries AD, Reeve PA, Nyangulu DS, Wirima JJ. Nutrition in pulmonary tuberculosis: a comparison of African patients from Malawi and Nigeria. East Afr Med J 1987; 64: 643–647.
Harries AD, Nkhoma WA, Thompson PJ, Nyangulu DS, Wirima JJ. Nutritional status in Malawian patients with pulmonary tuberculosis and response to chemotherapy. Eur J Clin Nutr 1988; 42: 445–450.
Kennedy N, Ramsay A, Uiso L, Gutmann J, Ngowi FI, Gillespie SH. Nutritional status and weight gain in patients with pulmonary tuberculosis in Tanzania. Trans R Soy Trop Med Hyg 1996; 90: 162–166.
Onwubalili JK. Malnutrition among tuberculous patients in Harrow, England. Eur J Clin Nutr 1988; 42: 363–366.
Macallan DC, McNurlan MA, Kurpad AV, de Souza G, Shetty PS, Calder AG, Griffin GE. Whole body protein metabolism in human pulmonary tuberculosis and undernutrition: evidence for anabolic block in tuberculosis. Clin Sci 1998; 94: 321–331.
Mehta JB, Fields CL, Byrd RP, Roy TM. Nutritional status and mortality in respiratory failure caused by tuberculosis. Tennessee Med 1996; (October):369–371.
Paton NI, Castello-Branco LR, Jenning G, et al. Impact of tuberculosis on the body composition of HIV-infected men in Brazil. J Acquired Immune Defic Syndr Hum Retrovirol 1999; 20: 265–271.
Shimeles D, Lulseged S. Clinical profile and pattern of infection in Ethiopian children with severe protein-energy malnutrition. East Afr Med J 1994; 71: 264–267.
Adegbola RA, Falade AG, Sam BE, Aidoo M, Baldeh I, Hazlett D, et al. The etiology of pneumonia in malnourished and well-nourished Gambian children. Pediatr Infect Dis J 1994; 13: 975–982.
Ikeogu MO, Wolf B, Mathe S. Pulmonary manifestations in HIV seropositivity and malnutrition in Zimbabwe. Arch Dis Child 1997; 76: 124–128.
Chan J, Tian Y, Tanaka KE, Tsang MS, Yu K, Salgame P, et al. Effects of protein calorie malnutrition on tuberculosis in mice. Proc Natl Acad Sci USA 1996; 93:14, 857–14, 861.
Doherty ML, Monaghan ML, Bassett HF, Quinn PJ, Davis WC. Effect of dietary restriction on cell-mediated immune responses in cattle infected with Mycobacterium bovis. Vet Immunol Immunopathol 1996; 49: 307–320.
Bartow RA, McMurray DN. Erythrocyte receptor (CD2)-bearing T lymphocytes are affected by diet in experimental pulmonary tuberculosis. Infect Immun 1990; 58: 1843–1847.
McMurray DN, Bartow RA Immunosuppression and alteration of resistance to pulmonary tuberculosis in guinea pigs by protein undernutrition. J Nutr 1992; 122: 738–743.
Getz HR, Koerner TA. Vitamin A and ascorbic acid in pulmonary tuberculosis. Determination in plasma by the photoelectric colorimeter. Am J Med Sci 1941; 202:831–847.
Getz HR, Westfall IS, Henderson HJ. Nutrition in tuberculosis as evaluated by blood analysis. Am Rev Tuberc 1944; 50: 96–111.
Prokopiev DI. Vitamin A content and carotene in blood plasma in pulmonary tuberculosis. Ter Arkh 1966; 38: 54–59.
Evans DIK, Attock B. Folate deficiency in pulmonary tuberculosis: relationship to treatment and to serum vitamin A and beta-carotene. Tubercle 1971; 52: 288–294.
Crimm PD, Short DM. Vitamin A content of the human liver in tuberculosis. Ann Intern Med 1939; 13: 61–63.
Moore T, Sharman IM. Vitamin A levels in health and disease. Br J Nutr 1951; 5: 119–129.
Getz HR, Hildebrand GB, Finn M. Vitamin A deficiency in normal and tuberculous persons as indicated by the biophotometer. JAMA 1939; 112: 1308–1311.
Harris R, Harter JS. Night blindness and vitamin A deficiency in pulmonary tuberculosis. South Med J 1940; 33: 1064–1065.
Solon FS, Popkin BM, Fernandez TL, Latham MC. Vitamin A deficiency in the Philippines: a study of xerophthalmia in Cebu. Am J Clin Nutr 1978; 31: 360–368.
Breese BB, Watkins E, McCoord AB. The absorption of vitamin A in tuberculosis. JAMA 1942; 119: 3–4.
Rwangabwoba JM, Fischman H, Semba RD. Serum vitamin A levels during tuberculosis and human immunodeficiency virus infection. Intl J Tuberc Lung Dis 1998; 2: 771–773.
Smith MI. Studies on nutrition in experimental tuberculosis. I. The effect of fat-soluble A vitamine on tuberculosis of the guinea pig, with especial reference to the value of codliver oil in experimental tuberculosis. Am Rev Tuberc 1923; 7: 33–48.
Steiner M, Greene MR, Kramer B. The effect of vitamin-A deficiency on experimental tuberculosis in the guinea pig and rabbit. Am Rev Tuberc 1937; 36: 222–238.
Otero PM, Koppisch E, Axtmayer JH. Influence of dietary factors upon the resistance of the white rat to experimental tuberculosis. I. Vitamin A deficiency. Puerto Rico J Public Health Trop Med 1934; 9: 314–320.
Gloyne SR, Page DS. A preliminary note on the relationship between deficiency in vitamin A and tuberculosis. Tubercle 1921; 3: 577–579.
Sriramachari S, Gopalan C. Nutrition and tuberculosis: effect of some nutritional factors on resistance to tuberculosis. Indian J Med Res 1958; 46: 105–112.
Hagedorn K. Versuche an Ratten über den Einfluß des Vitaminmangels auf den Verlauf der Tuberkulose. Beitr Klin Tuberk spezif Tuberk Forsch 1928; 70:389–407, 1929; 72: 1–31.
Finkelstein MH. Effect of carotene on course of B. tuberculosis infection of mice fed on a vitamin A deficient diet. Proc Soc Exp Biol Med 1932; 29: 969–971.
Solotorovsky M, Squibb RL, Wogan GN, Siegel H, Gala R. The effect of dietary fat and vitamin A on avian tuberculosis in chicks. Am Rev Resp Dis 1961; 84: 226–235.
Wells JW. A Comparative Study of the Influence of Cod-Liver Oil, and Cod-Liver Oil Emulsion upon the Nutrition of Normal and Tuberculous Pigs. Manchester, UK: Manchester University Press, 1907.
Sklan D, Melamed D, Friedman A. The effect of varying levels of dietary vitamin A on immune response in the chick. Poult Sci 1994; 73: 843–847.
Crowle AJ, Ross EJ. Inhibition by retinoic acid of multiplication of virulent tubercle bacilli in cultured human macrophages. Infect Immun 1989; 57: 840–844.
Malkovsky M, Medawar PB. Is immunological tolerance (non-responsiveness) a consequence of interleukin-2 deficit during the recognition of antigen? Immunol Today 1984; 5: 340.
Malkovsky M, Medawar PB, Thatcher DR, Toy J, Hunt R, Rayfield LS, Dore C. Acquired immunological tolerance of foreign cells is impaired by recombinant interleukin 2 or vitamin A acetate. Proc Natl Acad Sci USA 1985; 82: 536–538.
Ferraro F, Mattei M, Colizzi V. Low doses of recombinant interleukin-2 enhanced delayed type hypersensitivity to PPD in mice infected with Mycobacterium bovis-BCG and fed a diet supplemented with vitamin A acetate. Z Erkrank Atm org 1988; 171: 45–49.
Davies PDO. A possible link between vitamin D deficiency and impaired host defence to Mycobacterium tuberculosis. Tuberculosis 1985; 66: 301–304.
Douglas AS, Strachan DP, Maxwell JD. Seasonality of tuberculosis: the reverse of other respiratory diseases in the UK. Thorax 1996; 51: 944–946.
Thomasset M. Vitamine D et systeme immunitaire. Pathol Biol (Paris) 1994; 42: 163–172.
Crowle AJ, Ross EJ, May MH. Inhibition by 1,25(OH)2-vitamin D3 of the multiplication of virulent tubercle bacilli in cultured human macrophages. Infect Immunity 1987; 55: 2945–2950.
Rook GA, Steele J, Fraher L, Barker S, Karmali R, O’Riordan J, Stanford J. Vitamin D3, gamma interferon, and control of proliferation of Mycobacterium tuberculosis by human monocytes. Immunology 1986; 57: 159–163.
Rook GA, Taverne J, Steele J, Altes C, Stanford JL. Interferon gamma, cholecalciferol metabolites, and the regulation of anti-mycobacterial and immunopathological mechanisms in human and murine macrophages. Bull Intl Union Tuberc Lung Dis 1987; 62: 41.
Denis M. Killing of Mycobacterium tuberculosis within human monocytes: activation by cytokines and calcitriol. Clin Exp Immunol 1991; 84: 200–206.
Crowle AJ, Salfinger M, May MH. 1,25(OH2)-vitamin D3 synergizes with pyrazinamide to kill tubercle bacilli in cultured human macrophages. Am Rev Respir Dis 1989; 139: 549–552.
McMurray DN, Bartow RA, Mintzer CL, Hernandez-Frontera E. Micronutrient status and immune function in tuberculosis. Ann NY Acad Sci 1990; 587: 59–69.
Hafiez AA, Abdel-Hafez MA, Salem D, Abdou MA, Helaly AA, Aarag AH. Calcium homeostasis in untreated pulmonary tuberculosis. Kekkaku 1990; 65: 308–316.
Bradley GW, Sterling GM. Hypercalcaemia and hypokalaemia in tuberculosis. Thorax 1978; 33: 464–467.
Davies PD, Church HA, Brown RC, Woodhead JS. Raised serum calcium in tuberculosis patients in Africa. Eur J Respir Dis 1987; 71: 341–344.
Fuss M, Karmali R, Pepersack T, Bergans A, Dierckx P, Prigogine T, et al. Are tuberculous patients at a great risk from hypercalcemia? Q J Med 1988; 69: 868–678.
Grange JM, Davies PD, Brown RC, Woodhead JS, Kardjito T. A study of vitamin D levels in Indonesian patients with untreated pulmonary tuberculosis. Tubercle 1985; 66: 187–191.
Chan TY, Poon P, Pang J, Swaminathan R, Chan CH, Nisar M, Williams CS, Davies PD. A study of calcium and vitamin D metabolism in Chinese patients with pulmonary tuberculosis. J Trop Med Hyg 1994; 97: 26–30.
Davies PD, Church HA, Brown RC, Woodhead JS. Raised serum calcium in tuberculosis patients in Africa. Eur J Respir Dis 1987; 71: 341–344.
Davies PD, Brown RC, Woodhead JS. Serum concentrations of vitamin D metabolites in untreated tuberculosis. Thorax 1985; 40: 187–190.
Williams SE, Wardman AG, Taylor GA, Peacock M, Cooke JN. Long term study of the effect of rifampicin and isoniazid on vitamin D metabolism. Tubercle 1985; 66: 49–54.
Kitrou MP, Phytou-Pallikari A, Tzannes Se, Virvidakis K, Mountokalakis TD. Serum calcium during chemotherapy for active pulmonary tuberculosis. Eur J Respir Dis 1983; 64: 347–354.
Brodie MJ, Boobis AR, Hillyard CJ, Abeyasekera G, MacIntyre I, Park BK. Effect of isoniazid on vitamin D metabolism and hepatic monooxygenase activity. Clin Pharmacol Ther 1981; 30: 363–367.
Perry W, Erooga MA, Brown J, Stamp TC. Calcium metabolism during rifampicin and isoniazid therapy for tuberculosis. J Roy Soc Med 1982; 75: 533–536.
Markkanen T, Levanto A. Sallinen V, Virtanen S. Folic acid and vitamin B12 in tuberculosis. Scand J Haemat 1967; 4: 283–291.
Cameron SJ, Home NW. The effect of tuberculosis and its treatment on erythropoiesis and folate activity. Tubercle 1971; 52: 37–48.
Knox-Macaulay HHM. Serum cobalamin concentration in tuberculosis. A study in the Guinea savanna of Nigeria. Trop Geog Med 1990; 42: 146–150.
Getz HR, Long ER, Henderson HJ. A study of the relation of nutrition to the development of tuberculosis. Influence of ascorbic acid and vitamin A. Am Rev Tuberc 1951; 64: 381–393.
McConkey M, Smith DT. The relation of vitamin C deficiency to intestinal tuberculosis in the guinea pig. J Exp Med 1933; 58: 503–512.
Finch PJ, Millard FJC, Maxwell JD. Risk of tuberculosis in immigrant Asians: culturally acquired immunodeficiency? Thorax 1991; 46: 1–5.
Strachan DP, Powell KJ, Thaker A, Millard FJC, Maxwell JD. Vegetarian diet as a risk factor for tuberculosis in immigrant south London Asians. Thorax 1995; 50: 175–180.
Chanarin I, Stephenson E. Vegetarian diet and cobalamin deficiency: their association with tuberculosis. J Clin Pathol 1988; 41: 759–762.
McMurray DN, Yetley EA. Response to Mycobacterium bovis BCG vaccination in protein-and zinc-deficient guinea pigs. Infect Immun 1983; 39: 755–761.
Corr WP Jr, Kyle RA, Bowie EJW. Hematologic changes in tuberculosis. Am J Med Sci 1964; 248: 709–714.
Baynes BD, Flax H, Bothwell TH, Bezwoda WR, MacPhail AP, Atkinson P, Lewis D. Haematological and iron-related measurements in active pulmonary tuberculosis. Scand J Haematol 1986; 36: 280–287.
Morris CDW, Bird AR, Nell H. The haematological and biochemical changes in severe pulmonary tuberculosis. Q J Med 1989; 272: 1151–1159.
Ramakrishnan CV, Rajendran K, Jacob PG, Fox W, Radhakrishna S. The role of diet in the treatment of pulmonary tuberculosis. An evaluation in a controlled chemotherapy study in home and sanatorium patients in south India. Bull WHO 1961; 25: 339–359.
Downes J. An experiment in the control of tuberculosis among Negroes. Milbank Mem Fund Q 1950; 28: 127–159.
Getz HR. A physiologic and clinical study of failures in vitamin A metabolism in tuberculous patients. Am Rev Tuberc Pulm Dis 1955; 72: 218–227.
Hanekom WA, Potgieter S, Hughes EJ, Malan H, Kessow G, Hussey GD. Vitamin A status and therapy in childhood pulmonary tuberculosis. J Pediatr 1997; 131: 925–927.
Kent PT, Kubica GP. Public Health Mycobacteriology: A Guide for the Level III Laboratory. U.S. Department of Public Health and Human Services, Public Health Service. Atlanta: Centers for Disease Control, 1985.
International Union Against Tuberculosis and Lung Disease. Technical guide for sputum examination for tuberculosis by direct microscopy. Bull Intl Union Against Tuber Lung Dis 1986; 61: 1–16.
Levy H, Feldman C, Sacho H, van der Meulen H, Kaltenbach J, Koornhof H. Reevaluation of sputum microscopy and culture in the diagnosis of pulmonary tuberculosis. Chest 1989; 95: 1193–1197.
Eisenach KD, Cave MD, Bates JH, Crawford JT. Polymerase chain reaction amplification of a repetitive DNA sequence specific for Mycobacterium tuberculosis. J Infect Dis 1990; 161: 977–981.
Anonymous. Biosafety in Microbiology and Biomedical Laboratories. Washington, DC: U.S. Government Printing Office, 1993.
Bass JB, Farer LS, Hopewell PC, O’Brien R, Jacobs RF, Ruben F, Snider DE Jr, Thornton G. Treatment of tuberculosis and tuberculosis infection in adults and children. Am J Resp Crit Care Med 1994; 149: 1359–1374.
American Thoracic Society. Treatment of tuberculosis and tuberculosis infection in adults and children. Am J Resp Crit Care Med 1994; 149: 1359–1374.
McDonald RJ, Memon AM, Reichman LB. Successful supervised ambulatory management of tuberculosis treatment failure. Ann Intern Med 1982; 96: 297–302.
Chaulk CP, Moore-Rice K, Rizzo R, Chaisson RE. Eleven years of community-based directly observed therapy for tuberculosis. JAMA 1995; 274: 945–951.
Moore RD, Chaulk CP, Griffiths R, Cavalcante S, Chaisson RE. Cost-effectiveness of directly observed versus self-administered therapy for tuberculosis. Am J Resp Crit Care Med 1996; 154: 1013–1019.
Caulk CP, Kazandjian VA. Directly observed therapy for treatment completion of pulmonary tuberculosis. Consensus statement of the Public Health Tuberculosis Guidelines Panel. JAMA 1998; 279: 943–948.
Weis SE, Slocum PC, Blais FX, King B, Nunn M, Matney GB, Gomez E, Foresman BH. The effect of directly observed therapy on the rates of drug resistance and relapse in tuberculosis. N Engl J Med 1994; 330: 1179–1184.
Zwarenstein M, Schoeman JH, Vundule C, Lombard CJ, Tatley M. Randomised controlled trial of self-supervised and directly observed treatment for tuberculosis. Lancet 1998; 352: 1340–1343.
Ferebee SH. Controlled chemoprophylaxis trials in tuberculosis: a general review. Adv Tuberc Res 1970; 17: 28–106.
Pape JW, Jean SS, Ho JL, Hafner A, Johnson WD Jr. Effect of isoniazid prophylaxis on incidence of active tuberculosis and progression of HIV infection. Lancet 1993; 342: 268–272.
Gordin FM, Matts JP, Miller C, Brown LS, Hafner R, John SL, et al. A controlled trial of isoniazid in persons with anergy and human immunodeficiency virus infection who are at high risk for tuberculosis. N Engl J Med 1997; 337: 315–320.
Chaisson RE, Gordin F, Matts J, Garcia L, Hafner R, Obrien R. A randomized trial of rifampin/ pyrazinamide for 2 months vs. INH for 12 months in HIV+ tuberculin+ adults. Abstract 447/22126. Geneva: 12th World AIDS Conference, June 28—July3, 1998, Conference Record, p. 287.
Halsey NA, Coberly JS, Desormeaux J, Losikoff P, Atkinson J, Moulton LH, et al. Randomised trial of isoniazid versus rifampicin and pyrazinamide for prevention of tuberculosis in HIV-1 infection. Lancet 1998; 351: 786–792.
Rodrigues LA, Diwan VK, Wheeler JG. Protective effect of BCG against tuberculous meningitis and miliary tuberculosis: a meta-analysis. Intl J Epidemiol 1993; 22: 1154–1158.
Centers for Disease Control and Prevention. Guidelines for the prevention of the transmission of Mycobacterium tuberculosis in health-care facilities. MMWR 1994; 43: 1–111.
Segal-Maurer S, Kalkut GE. Environmental control of tuberculosis: continuing controversy. Clin Infect Dis 1994; 19: 299–308.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2001 Springer Science+Business Media New York
About this chapter
Cite this chapter
Whalen, C., Semba, R.D. (2001). Tuberculosis. In: Semba, R.D., Bloem, M.W. (eds) Nutrition and Health in Developing Countries. Nutrition ◊ and ◊ Health. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-225-8_9
Download citation
DOI: https://doi.org/10.1007/978-1-59259-225-8_9
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-4757-6052-1
Online ISBN: 978-1-59259-225-8
eBook Packages: Springer Book Archive